VitalStone Financial’s Biofrontera BFRI Stock Holding History

VitalStone Financial’s Portfolio BFRI Stock Details BFRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15	Closed	-$2K	–	915
2023 Q1	$2K	Buy	+15	New	+$234	﹤0.01%	295

Other funds holding BFRI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

VitalStone Financial's BFRI Position: Q2 2023 in Review

VitalStone Financial sold out of Biofrontera (BFRI) in Q2 2023, closing a stake of 15 shares — an estimated $2K sold.

VitalStone Financial first reported a position in BFRI in Q1 2023 and held it in 1 quarter. The position peaked at $2K in Q1 2023. 13 funds tracked by Wall St. Rank hold BFRI as of Q2 2023.

VitalStone Financial reported no remaining Biofrontera position as of Q2 2023 after selling out during the quarter.
VitalStone Financial sold 15 Biofrontera shares in Q2 2023, an estimated $2K.
VitalStone Financial first reported a position in Biofrontera in Q1 2023 and held it in 1 quarter.
VitalStone Financial's Biofrontera position peaked at $2K in Q1 2023.
13 funds tracked by Wall St. Rank held Biofrontera as of Q2 2023.

Based on VitalStone Financial's 13F filing for Q2 2023, filed 21 Aug 2023.